Reducing Problematic Substance Use in Youth With Chronic Medical Conditions
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01709201|
Recruitment Status : Withdrawn (Study did not receive funding and was administratively withdrawn.)
First Posted : October 18, 2012
Last Update Posted : June 21, 2017
|Condition or disease||Intervention/treatment|
|Alcohol Abuse Drug Abuse||Behavioral: Brief Intervention|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Reducing Problematic Substance Use in Youth With Chronic Medical Conditions|
|Study Start Date :||July 2013|
|Estimated Primary Completion Date :||December 2014|
|Estimated Study Completion Date :||June 2015|
No Intervention: Treatment as Usual
Those in the Treatment as Usual group will not receive the brief intervention for substance use but will receive a brief health education brochure.
Experimental: Brief Intervention
Those in the Brief Intervention group will receive a brief motivational intervention aimed at encouraging the participant to decrease their substance use.
Behavioral: Brief Intervention
Those in the intervention arm will undergo a 10-minute discussion with a trained interventionist aimed at encouraging decreased substance use.
- Percent days abstinent [ Time Frame: 30 days post baseline ]We will compare the percent days abstinent from substances between the Treatment as Usual and Intervention groups 30 days post baseline
- Medical complications [ Time Frame: 30 days post baseline ]We will evaluate the incidents of disease complications between the Treatment as Usual and Intervention groups 30 days post baseline
- Percent Days Abstinent 90 days post baseline [ Time Frame: 90 days post baseline ]We will compare the percent days abstinent from substances between the Treatment as Usual and Intervention groups 90 days post baseline
- Medical complications 90 days post baseline [ Time Frame: 90 days post baseline ]We will evaluate the incidents of disease complications between the Treatment as Usual and Intervention groups 30 days post baseline
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01709201
|United States, Massachusetts|
|Boston Children's Hospital|
|Boston, Massachusetts, United States, 02115|
|Principal Investigator:||Sharon Levy, MD, MPH||Boston Children’s Hospital|
|Principal Investigator:||Elissa Weitzman, ScD, MSc||Boston Children’s Hospital|